Testing for SARS-COV-2
Testing, Testing, Testing… The uncertainties about SARS-CoV-2 include critical questions such as what the death rate is for infected people, and what the infection rate is for the general public. This makes testing for infection of critical importance. There are numerous ways to establish the presence of infection. One is recovery of live virus, which…
Antivirals in the Time of Coronavirus
An Evaluation of Remdesivir and Hydroxychloroquine Many years ago, efforts to contain HIV resulted in the first widespread successful use of antiviral drugs, including deoxynucleotide analogs such as AZT, able to terminate reverse transcription of viral RNA. The current coronavirus pandemic has spurred extensive efforts to identify effective and safe anti-SARS-CoV-2 drugs. Recent reports have…
Dr. Robert Gallo Exclusive Broadcast Interview with Walter Isaacson of Amanpour & Co.
Can an Oral Polio Vaccine Help Stop COVID-19? Please see this just released Associated Press article, “Could old vaccines for other germs protect against COVID-19?” with Dr. Robert Gallo (Institute of Human Virology at the University of Maryland School of Medicine) and Dr. Konstantin Chumakov (U.S. Food and Drug Administration), both of the Global Virus…
Global Virus Network’s Institute of Human Virology and Italian Scientists Identify Unique Mutations in SARS-CoV-2 Found in Europe and North America
BALTIMORE, MD, April 9, 2020: The Institute of Human Virology (IHV) at the University of Maryland School of Medicine, a Global Virus Network (GVN) Center of Excellence, and scientists from Trieste, Italy announced today the characterization of a novel mutation in the RNA polymerase of certain viral strains of SARS-CoV-2 carried by patients located in…
Editorial from Dr. Christian Brechot and Dr. Robert Gallo
The SARS-CoV-2 epidemic is spreading and has become a pandemic with a major impact on national health systems and economics, as well as population behaviors. Delineating the future of the pandemic expansion and the geographical areas which will be hit has important consequences as to the capacity to be prepared and take adequate measures to…
ENHANCED MODEL FOR MONITORING ZONES OF INCREASED RISK OF COVID-19 SPREAD
Research By GVN Scientists Establishes Link Between Temperature, Latitude, Spread & Seasonality Baltimore, MD, March 10, 2020: Scientists affiliated with the Global Virus Network (GVN), the worldwide coalition of preeminent virologists engaged in the preparedness, defense and first research response to emerging, existing and unidentified viruses that pose a clear and present threat to public…
Global Virus Network (GVN) Coordinates Efforts Between Top International Experts Researching COVID-19
The GVN Is Connecting Academia, Governments, Public Health Organizations and Industry to Advance the Response for COVID-19 and Prepare for the Next Outbreak Baltimore, Maryland, USA, February 18, 2020: The Global Virus Network (GVN), representing 53 Centers of Excellence and 9 Affiliates in 32 countries comprising foremost experts in every class of virus causing disease…
Global Virus Network (GVN) Convenes Discussions with International Top Experts to Combat Growing Novel Coronavirus Epidemic
The GVN Is Bridging Gaps in the Global Emergency Response and Serving as a “Go-To” Resource for Members Needing Assistance in Obtaining and Disseminating Cutting-Edge Scientific Research Baltimore, Maryland, USA, February 6, 2020: The Global Virus Network (GVN), representing 53 Centers of Excellence and 9 Affiliates in 32 countries comprising foremost experts in every class…
Global Virus Network (GVN) Experts Combat New Worldwide Coronavirus Outbreak
GVN stands by China and relevant international organizations to support efforts to mitigate the new strain of coronavirus, named 2019-nCoV Baltimore, Maryland, USA, January 30, 2020: As airlines suspend flights, countries evacuate citizens from China and nearly 60 million Chinese experience a lockdown, the Global Virus Network (GVN), representing 53 Centers of Excellence and 9…